THE Aesthetic Show Advances $34 Billion Market
LAS VEGAS, May 14 /PRNewswire/ -- More than 2,000 physicians, researchers, Wall Street analysts and industry executives will gather at the Mandalay Bay Resort for THE Aesthetic Show, May 30 - June 1, 2008. With the most comprehensive and progressive medical aesthetic educational program ever assembled in the U.S., this unique venue is focused on accelerating and sustaining the development of a $34 billion global market for aesthetic treatments.
"THE Aesthetic Show offers a weekend immersion in everything new and relevant in the aesthetic procedure business," said Michael Moretti, President of Medical Insight, Inc. and Chairman of THE Aesthetic Show. "We specifically designed this sophisticated show to serve the needs of both aesthetic practices and the supporting industry by breaking down the artificial barriers between various competing medical subspecialties. Unlike exclusive medical society meetings, THE Aesthetic Show makes high-level educational content and new ideas accessible to all of our attendees."
Faculty members of THE Aesthetic Show include the top anti-aging, cosmetic surgery and aesthetic medicine experts in the world, as well as some of the highest visibility celebrity physicians in the field. "Our attendees will enjoy three days of direct access to over 50 of the elite thought leaders who are driving the advancement and cultural mainstreaming of aesthetic medicine," explained Mr. Moretti. "Every relevant subject from the latest plastic surgery techniques to avant-garde body shaping and home use devices will be presented and evaluated in one weekend. This scientific program also offers 25 intensive one-hour workshops featuring interactive training sessions with patient treatments."
Leading corporate sponsors of THE Aesthetic Show include: Allergan Medical (NYSE: AGN), BioForm Medical (Nasdaq: BFRM), Candela (Nasdaq: CLZR), Cutera (Nasdaq: CUTR), Cynosure (Nasdaq: CYNO), Dermik Aesthetics, Galderma Laboratories, Johnson & Johnson (NYSE: JNJ), Mentor Corporation (NYSE: MNT), Merz Pharmaceuticals, Palomar Medical Technologies (Nasdaq: PMTI), Syneron (Nasdaq: ELOS) and Thermage (Nasdaq: THRM).
According to a recent research report released by Medical Insight (miinews.com), the global market for aesthetic products will exceed $5.4 billion in 2008. This dynamic market is expected to reach $8.5 billion by 2012. On a procedure level, aesthetic practices will perform 89 million treatments in 2008 generating $34 billion in practice revenues. Annual procedure volume will grow to 139 million treatments by 2012, producing $52 billion in patient fees, as consumers increasingly opt for more advanced, premium-priced procedures.
THE Aesthetic Show will be held at the Mandalay Bay Resort in Las Vegas from May 30 - June 1, 2008. To register or view the program, visit http://www.aestheticshow.com or contact Silvia Kraniess at Silvia@aestheticshow.com.
About Medical Insight, Inc.
Medical Insight, Inc. is the industry leader in sector and custom market research. Led by founder Michael Moretti, Medical Insight, Inc. has reported data for over 20 years on procedure volume, revenues, product sales, new product introductions, market forecasts and trend analysis. For information on products and services offered by Medical Insight, Inc., visit http://www.MiiNews.com.
Contact: Medical Insight, Inc.
Michael Moretti, 949/830-5409
Email: mmoretti@MiiNews.com
BODY SHAPING AND SKIN TIGHTENING DRIVE GLOBAL AESTHETIC INDUSTRY TO $15 BILLION BY 2011
Global Aesthetic Market Study from Medical Insight, Inc.
Charts Growth Path with Comprehensive Data and Forecasts
Aliso Viejo, CA - July 30 - Over the next five years, the emerging market segments of body shaping and skin tightening will be prime catalysts behind unprecedented growth in the global aesthetic industry, according to the just-released Global Aesthetic Market research report from Medical Insight, Inc.
This report, which provides in-depth analysis and a five-year forecast of the $8.4 billion global aesthetic industry, indicates these relatively new categories will play prominent roles in record industry growth, projected to increase by 12.5% annually and reach $15.3 billion by 2011. Among highlights in the newest edition of this annual market study:
- Total worldwide sales of aesthetic equipment, currently estimated at $1.2 billion, will rise by 10.3% per year, reaching over $1.9 billion in 2011. Total related fees will grow 16.1% annually, to $34.9 billion during the same period.
- Body shaping and skin tightening devices will drive aggressive expansion in the device category, with CAGRs of 20.7% and 15.7% respectively, escalating from $231.6 million in 2006 to $564.5 million in global sales by 2011.
"Five years ago, skin tightening and body shaping were pipeline industries, embraced by forward-looking companies seeking to expand market share," said Michael Moretti, President of Medical Insight, Inc. and editor of the 400-page Global Aesthetic Market Study. "The rapid emergence of energy-based technologies and innovative devices are creating new sources of revenue for brands currently in the market and will pave the way for others to enter the field. These modalities will also drive growth in the lucrative non-physician aesthetic category, including medispas and corporate franchises."
Body shaping encompasses a range of procedures that target size and weight reduction, as well as toning, firming and cellulite treatment. Skin tightening procedures address wrinkles and skin laxity on the face and body. In 2006, over 14 million procedures were performed in this category, generating in excess of $4 billion in practitioner fees.
"By 2011, we'll see more than 36 million procedures in these areas, producing over $8 billion in professional fees," according to Moretti. "U.S. fee growth will outpace that of the rest of the world as the U.S continues to support strong demand and high pricing."
Another important factor expanding manufacturer revenues in this space is sales of disposable components for aesthetic devices. Over the next five years, sales of disposables are expected to rise strongly by 39.7% per year to more than $400.6 million.
Public companies detailed in this report include Allergan (NYSE: AGN), Candela (Nasdaq: CLZR), Cutera (Nasdaq: CUTR), Cynosure (Nasdaq: CYNO), Iridex (Nasdaq: IRIX), J&J (NYSE:JNJ), Medicis (NYSE:MRX), Mentor (NYSE: MNT), Obagi (Nasdaq: OMPI), Palomar (Nasdaq: PMTI), P&G (NYSE:PG), Syneron (Nasdaq: ELOS) and Thermage (Nasdaq: THRM). Numerous private companies, including many new ventures, are also profiled.
The Global Aesthetic Market Study provides critical information on every segment of the aesthetic industry including skin tightening systems, body shaping devices, dermal fillers, laser and light-based equipment, botulinum toxins, emerging skin rejuvenation technologies, home-based aesthetic devices and anti-aging topicals. For more information and to preview a Table of Contents and Executive Summary, visit www.miinews.com.
About Medical Insight, Inc.
Medical Insight, Inc. is the industry leader in sector and custom market research. Led by founder Michael Moretti, Medical Insight, Inc. has reported data for over 20 years on procedure volume, revenues, product sales, new product introductions, market forecasts and trend analysis.
THE AESTHETIC SHOW FEATURES WORLD-CLASS AESTHETIC EXPERTS
Unique Conference Charts Future Direction For $25 Billion Aesthetic Market
LAS VEGAS, April 24 /PRNewswire/ -- THE Aesthetic Guide, the leading publication for global aesthetic medical news, today announced keynote speakers and program details for THE Aesthetic Show, May 25-27 at the Mandalay Bay Resort, Las Vegas.
Dr. Jason Diamond, facial plastic surgeon from "Dr. 90210," and Dr. Ava Shamban, featured dermatologist on "Extreme Makeover," will headline the opening day Media Panel, "Defining Contemporary Aesthetic Medicine." These high-profile Los Angeles physicians are among dozens of experts speaking on a range of high-growth procedures, new technologies and practice development advice.
"THE Aesthetic Show will offer the industry's most progressive and comprehensive program on the science and business of body rejuvenation," said Michael Moretti, Publisher of THE Aesthetic Guide and Chairman of THE Aesthetic Show. "We are breaking the mold of the traditional medical society conference to design a dynamic educational experience which encourages direct attendee interaction with our expert faculty and high-level industry executives. This program is designed to support the next generation of mega-practices that will grow the $25 billion global aesthetic procedure market."
THE Aesthetic Show will feature clinical presentations, technical exhibits, and hands-on workshops covering the hottest aesthetic procedures, including facial skin rejuvenation, skin tightening, body shaping and the new class of long-lasting facial injectables. Practice-building seminars for the modern aesthetic practice are also on the agenda.
"The worlds of science and beauty have crossed paths to create an entirely new medical discipline focused on rejuvenation," said Dr. Shamban, owner of the Laser Institute for Dermatology and Assistant Clinical Professor of Dermatology at UCLA. "We now have access to cutting-edge technologies and true scientific advancements that will help us provide the best aesthetic care for our patients ... and it will only improve in years to come."
Robert Grant, President of Allergan Medical (NYSE: AGN), will join an opening night panel discussion and is keynote speaker at Saturday's luncheon. Other corporate pioneers sponsoring THE Aesthetic Show include Mentor (NYSE: MNT), Medicis (NYSE: MRX), Johnson & Johnson (NYSE: JNJ), Cutera (Nasdaq: CUTR), Candela (Nasdaq: CLZR), Cynosure (Nasdaq: CYNO), Palomar (Nasdaq: PMTI) and Syneron (Nasdaq: ELOS).
THE Aesthetic Show faculty features luminaries from plastic surgery and cosmetic dermatology, including Marta Rendon, MD, Assistant Clinical Professor, University of Miami; Mark Rubin, MD, Assistant Clinical Professor of Dermatology, University of California, San Diego; and Thomas Romo III, MD, Director of Facial Plastic and Reconstructive Surgery, Lenox Hill Hospital, New York City. According to Dr. Romo, Moderator for "The Art of Body Shaping" session, THE Aesthetic Show offers a vital link between the aesthetic physician and tools available to provide optimum patient care.
"Contemporary aesthetics requires constant education," said Dr. Romo. "Today, naturalness is more important than looking younger - and rapid recovery is the new philosophy. It's critical for physicians to be in sync with the newest minimally invasive and surgical options."
For more information about THE Aesthetic Show, visit www.aestheticshow.com.
THE Aesthetic Guide LAUNCHES THE AESTHETIC SHOW
Unique Multidisciplinary Forum Redefines Aesthetic Medical Education
Aliso Viejo, CA - March 13, 2007 - THE Aesthetic Guide, the leading publication for global aesthetic medicine news and information, today announced the debut of THEAesthetic Show, a multidisciplinary physician forum designed as the ultimate educational and networking experience for the dynamic aesthetic medical market.
Scheduled for May 25-28, 2007 at Mandalay Bay Convention Center in Las Vegas, THEAesthetic Show will present new aesthetic procedures, products and technologies in a highly innovative, high-tech setting featuring live demonstrations, luminary presentations, interactive webcasts, and exclusive networking events. Unlike traditional single specialty meetings, THEAesthetic Show is open to all medical professionals and will focus on the aesthetic medical category.
"We are taking a very progressive approach to defining the next level in education for this multi-billion dollar industry," said Michael Moretti, publisher of THE Aesthetic Guide. "Physicians from diverse specialties will have unparalleled access to cutting-edge technologies, pioneering corporations and key opinion leaders in a modernized approach to medical education."
According to Moretti, THEAesthetic Show program will feature an ongoing series of workshops, demonstrations and scientific discussions supported by corporate leaders including: Allergan (NYSE:AGN), Mentor (NYSE:MNT), Medicis (NYSE:MRX), Johnson & Johnson (NYSE:JNJ), Syneron (NASD:ELOS), Candela (NASD:CLZR), Cynosure (NASD:CYNO) and Palomar (NASD:PMTI).
Topics featured at THEAesthetic Show are focused on "the science of rejuvenation," and include body-shaping/contouring, skin rejuvenation/tightening, facial injectables, hair and tattoo removal, cosmeceuticals and practice marketing/medi-spa development.
THEAesthetic Show offers corporate sponsors the ability to design a unique show presence. The exhibit hall will incorporate live patient treatments and main-stage presentations. Hands-on workshops are planned throughout the weekend and webinar broadcasts are available during and after the show.
Industry scientists, executives, marketing experts and thought leaders from dermatology, plastic surgery, otolaryngology and oculoplastic surgery will provide a world-class curriculum. Faculty members on THEAesthetic Show roster include:
- Joel Cohen, M.D. dermatologic surgeon, AboutSkin Dermatology and DermSurgery; Denver, Colo.;
- David Goldberg, M.D., Clinical Professor of Dermatology, Mount Sinai School of Medicine;
- Mark Rubin, M.D., Assistant Clinical Professor of Dermatology, University of California, San Diego;
- Neil Sadick, M.D., Clinical Professor of Dermatology, Weill Medical College of Cornell University;
- Thomas Romo III, M.D., Director of Facial Plastic and Reconstructive Surgery, Lenox Hill Hospital;
- William Philip Werschler, M.D., Assistant Clinical Professor of Medicine/ Dermatology, University of Washington School of Medicine.
"THEAesthetic Show concept reflects the evolving reality of the current aesthetic market, where physicians and trained medical professionals from a variety of medical specialties work together to deliver cutting-edge aesthetic procedures to consumers," said Moretti.
For more information and to register, visit www.aestheticshow.com.
About THE Aesthetic Guide.
THE Aesthetic Guide is a publication of Medical Insight, Inc. featuring in-depth reports on new products, procedures and market trends, reaching 50,000 physicians, industry executives and analyst subscribers globally. Medical Insight, Inc. is the leading source of aesthetic industry data and market research (www.miinews.com).
Media Contact:
Fran Kelly
FSK Communications
E fkelly@comcast.net
T 732 706 5795
C 917 697 6471
GLOBAL
AESTHETIC MARKET STUDY HIGHLIGHTS NEW BUSINESS OPPORTUNITIES
The booming aesthetic procedure market is generating a wide array of
new business development opportunities, according to a new research report
released by Medical Insight, Inc. this week..
Light-based treatments are now mainstays of medical aesthetic practices.
In 2003, nearly 20 million hair removal, skin rejuvenation, tattoo and
pigmented lesion removal, acne reduction and photodynamic therapy treatments
were performed. These earned almost $6.5 billion for practitioners and
$372 million in revenue for equipment manufacturers. By 2008, this will
grow to over 53 million treatments annually earning practitioners $10.4
billion and manufacturers more than $612 million.
Botox treatments are also popular. In 2003, four million procedures were
performed worldwide, generating over $2.1 billion in procedure fees. By
2008, more than 10 million procedures will be performed annually, generating
treatment revenue of $4.4 billion. Revenue to suppliers will grow from
$656 million in 2003 to $1.6 billion in 2008.
Dermal filler use isn't far behind. More than two million procedures
were performed in 2003, earning practitioners $1.2 billion and suppliers
$196 million. In 2008, this will rise to almost five million treatments
generating $2.3 billion for physicians and $398 million for suppliers.
Microdermabrasion, chemical peels and emerging skin rejuvenation treatments
are also rising. In 2003, over 16 million treatments were performed, accounting
for almost $3.3 billion in fees to practitioners. Equipment manufacturers
and suppliers earned about $108 million. By 2008, this will grow to more
than 41 million procedures earning over $6 billion for practitioners and
$185 million for manufacturers.
The greatest growth and largest opportunity, however, remains anti-aging
topicals. In 2003, sales of all brands through all outlets accounted for
$4.1 billion. This will grow to more than $5.6 billion in 2008.
According to study author Michael Moretti, President of Medical Insight,
Inc. and Editor of THE Aesthetic Guide, the Global Aesthetic Market
study provides the only available comprehensive market analysis and five-year
forecast related to emerging and high-growth aesthetic market segments.
In addition to releasing the Global Aesthetic Market Study, Mr. Moretti
has identified a priority list of current business development and investment
opportunities, which is available upon request. "This Strategic Opportunities
Summary is designed to give business development executives, investors
and R&D managers immediate access to a select group of the most promising
new concepts in this exciting, high-growth field," explained Moretti.
To obtain an Executive Summary of the Global Aesthetic Market Study,
or receive the Strategic Opportunities Summary, contact Michael Moretti
at: Mmoretti@MiiNews.com
Mr. Moretti has served as an industry analyst, strategic business development
liaison, and editor in the high-tech medical / aesthetic field for 20
years.
Public companies participating in the aesthetic market include: Allergan
(NYSE: AGN), Biolase (Nasdaq:BLTI), Candela (Nasdaq:CLZR), Cutera (Nasdaq:CUTR),
Dusa (Nasdaq:DUSA), Inamed (Nasdaq:IMDC), Isolagen (AMEX: ILE), Laserscope
(Nasdaq:LSCP), Lumenis (Nasdaq:LUME), Medicis (NYSE:MRX), Palomar (Nasdaq:PMTI),
and PhotoMedex (Nasdaq:PHMD).\
For information on products and services offered by Medical Insight,
Inc., visit www.MiiNews.com or print
out our products and services order
form.
Contact: Michael Moretti
Medical Insight, Inc.
(949) 830-5409
Email: Mmoretti@MiiNews.com
AESTHETIC
FORUM PREVIEWS THE FUTURE OF AESTHETIC MEDICINE
On February 9, 2004 THE Aesthetic Guide will sponsor the annual
New Aesthetic Technologies Business Forum in Washington, D.C. Held concurrently
with the American Academy of Dermatology annual meeting, this private
symposium is designed as a forward-looking "crystal ball" for
progressive physicians and industry executives.
As with last year's Forum, we provide attendees with a highly selective
and condensed preview of things to come in 2004. For example, we presented
the first information on light emitting diodes for cosmetic applications
last year, and these devices are now fully commercialized and widely available.
We also previewed a new class of body-shaping technology, which is currently
sold by at least two suppliers in the U.S.
This year's Forum will begin with a comprehensive analysis of the global
aesthetic market, including estimates of procedure volume, procedure revenues,
product sales, and growth projections in all major categories of products
and services.
The fastest growing market segments for device-based procedures are cosmetic
PDT, skin rejuvenation and acne treatment. In addition, body shaping is
poised for tremendous procedure volume as newer and more effective technology
becomes available.
Dermal fillers will be strong components of this year's Forum program
as well. We will review the list of new materials pending approval or
in the R&D pipeline, including NewFill from Dermik Labs. Also competing
with fillers will be the fascinating autologous cell injection process
developed by Isolagen (Note: see Clinical Roundtable feature article in
this issue). Although this very unique technology is perhaps one year
from FDA approval in the U.S., it is currently used in clinical trials
and internationally with great success.
The next generation of anti-aging cosmeceuticals will be covered by a
well-known expert in the field. This category is virtually exploding as
the consumer appetite for physician-dispensed "high-end" anti-aging
formulas appears insatiable. We will quantify this market, and then point
to the types of products that will become very popular and profitable
in the near future.
One of the most exciting new technologies to debut at the Forum is the
Reliant Technologies "skin regeneration" system. This breakthrough
technology was developed by a design and clinical research team led by
Rox Anderson, M.D. and Richard Fitzpatrick, M.D. Working together with
the scientists that originally developed the UltraPulse carbon-dioxide
laser for skin resurfacing, this "laser dream team" has invented
a procedure that promises to make previous methods of facial resurfacing
and wrinkle removal obsolete.
In addition, many other technologies and new concepts will be discussed
during this highly interactive Forum session. If you consider yourself
in the elite group of aesthetic innovators, the Forum is designed to provide
you with inside information well in advance others. So, if you only have
time to attend one meeting this year, this is the one that will deliver
the greatest return on your investment of a few hours.
Note that the Forum is a private business meeting, with no connection
to manufacturers or medical societies, and has no affiliation with the
AAD annual meeting. Attendance must be arranged via advance registration.
To preregister for the Forum, please use the registration form in this
issue, visit our website at: MiiNews.com or email me directly at: Mmoretti@miinews.com
Michael Moretti
Editor/Publisher
Medical Insight, Inc.
AESTHETIC
BUYERS GUIDE REPORTS ON NEW DEVICE-BASED ACNE TREATMENTS
MISSION VIEJO, CALIF. – October 8, 2003 – Device-based acne
treatments are rapidly finding acceptance from physicians and patients,
according to clinical news reports in the most recent issue of the Aesthetic
Buyers Guide, published by Medical Insight, Inc.
The SkinStation from Radiancy, Inc. (Orangeburg, N.Y.) combines a safe
level of light energy and heat to treat acne. “I’m thrilled
because this device is extremely effective in some people, thereby eliminating
the need for oral treatment,” said Ava Shamban, M.D., a clinical
assistant professor of dermatology at the University of California School
of Medicine, Los Angeles. “SkinStation is a small, user-friendly
device. Treatment is comfortable for the patient, and it doesn’t
require a topical anesthetic.”
The ClearLight Acne Photoclearing System from Lumenis (Pleasanton, Calif.)
is a high-intensity blue light device for the treatment of moderate inflammatory
acne, and was the first such device approved by the FDA. “This is
a completely novel way to treat inflammatory acne, without requiring any
systemic medications or even using devices that are painful or ineffective,”
said Vic Narurkar, M.D., director at the Bay Area Laser Institute, San
Francisco, Calif.
The Smoothbeam System from Candela Corporation (Wayland, Mass.) is a
1450 nm diode laser that thermally alters the sebaceous glands at the
sites where acne lesions occur. Besides achieving an improvement in inflammatory
and comedonal acne, Smoothbeam “can safely treat all skin types,
regardless of pigmentation,” said Arielle Kauvar, M.D., a clinical
associate professor of dermatology at New York University School of Medicine.
Levulan photodynamic therapy (PDT) from DUSA Pharmaceuticals, Inc. (Wilmington,
Mass.) has been shown to effectively treat acne by clinical researchers.
According to Mark Nestor, M.D., Ph.D., a clinical associate professor
of dermatology and dermatologic surgery at the University of Miami School
of Medicine, Miami, Fla., “myself and others have had really outstanding
results overall in treating patients with moderate to severe acne.”
According to Michael Moretti, President of Medical Insight, Inc. and
Editor of THE Aesthetic Guide, "The market for acne treatment
devices is rapidly expanding as these innovative procedures offer physicians
and their patients viable options other than medications. Our market research
indicates that patients will pay cash for acne treatment procedures, and
this will have a powerful near-term influence on sales of related equipment
and cosmeceuticals."
Data on the emerging market for device-based acne treatment is available
via the New Aesthetic Technologies and Business Opportunities market study
published by Medical Insight. To receive an Executive Summary of this
report, contact Katie Davis at Kdavis@MiiNews.com,
or call (949) 830-5409 or visit www.MiiNews.com.
Public companies participating in the aesthetic market include: Allergan
(NYSE: AGN), Candela Corporation (Nasdaq:CLZR), DUSA (Nasdaq NMS: DUSA),
Inamed (Nasdaq:IMDC), Lumenis (Nasdaq:LUME), Medicis (NYSE:MRX) and Palomar
(Nasdaq:PMTI).
Contact:
Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
MEDICAL
INSIGHT RELEASES AESTHETIC PROCEDURE MARKET DATA
MISSION VIEJO, Calif.--September 18, 2003 – According to market
research conducted by Medical Insight, Inc., skin rejuvenation, wrinkle
removal, acne treatment and body shaping are currently the highest-growth
aesthetic procedure market segments. Medical Insight has developed a series
of market studies focused on these new business opportunities.
Medical Insight is also conducting an in-depth Aesthetic Practice Survey
involving every major cosmetic surgery practice in the U.S. This survey
provides detailed data on procedure pricing, brand loyalty and preferences,
market share by major manufacturer, satisfaction ratings of products and
suppliers, procedure volume statistics and product purchasing trends.
Results of this survey are available exclusively to Medical Insight clients.
According to Michael Moretti, President of Medical Insight, Inc. and
Editor of THE Aesthetic Guide, "Skin rejuvenation procedure
volume is forecast to grow to more than 29 million annual treatments in
2007, generating approximately $2.9 billion in fees. Wrinkle removal treatment
volume is expected to reach 5.6 million procedures earning $4.2 billion
in fees by 2007. Similarly, device-based acne treatment volume will grow
to 6.2 million procedures generating $2.3 billion in fees by the end of
this forecast period. And an estimated 9.4 million cellulite reduction
procedures will earn $9.4 billion for practitioners in 2007.”
Data on these high-growth market segments is available via several new
market reports, including: Next Generation Dermal Fillers; Cosmetic PhotoDynamic
Therapy; and New Aesthetic Technologies and Business Opportunities. To
receive Executive Summaries of these market studies, contact Katie Davis
at Kdavis@MiiNews.com, or call
(949) 830-5409 or visit www.MiiNews.com.
Public companies participating in the aesthetic market include: Allergan
(NYSE: AGN), Candela Corporation (Nasdaq:CLZR), DUSA (Nasdaq NMS: DUSA),
Inamed (Nasdaq:IMDC), Lumenis (Nasdaq:LUME), Medicis (NYSE:MRX) and Palomar
(Nasdaq:PMTI).
Contact:
Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
AESTHETIC
BUYERS GUIDE FEATURES EMERGING AESTHETIC TECHNOLOGIES AND PROCEDURES
MISSION VIEJO, Calif.--(BUSINESS WIRE)--May 12, 2003--The May issue of
THE Aesthetic Guide magazine provides an in-depth review of the
newest and most popular aesthetic technologies and products.
Light Emitting Diode (LED) systems are covered extensively in a feature
article on the subject. "This new generation of light devices is
expected to have a major impact on the aesthetic market due to low cost
and wide array of applications," said Michael Moretti, Editor of
THE Aesthetic Guide, and President of Medical Insight, Inc. "There
are numerous product development projects underway, and I expect that
LED-based devices will soon
be commercialized for home-use aesthetic applications."
Cosmetic applications of PhotoDynamic Therapy (PDT) using Levulan from
DUSA (Wilmington, Mass) is the subject of a clinical roundtable discussion
in the May THE Aesthetic Guide. Tina Alster, M.D. serves as the moderator
of this roundtable, which includes seven other leading cosmetic PDT researchers.
"Levulan PDT may become the highest volume aesthetic procedure within
a short period of time," commented Moretti. "The combined use
of this FDA-approved drug with a variety of light devices is proving extremely
advantageous in terms of improved clinical outcomes for treatment of such
skin conditions as acne, photoaging, and even pre-cancerous lesions."
THE Aesthetic Guide also focuses on new dermal fillers, which
represent one of the most exciting developments in aesthetics at this
time. Recent FDA approval of human collagen-based fillers (Cosmoderm/CosmoPlast)
from Inamed (Santa Barbara, Calif.), and a long list of competitive filler
products in the regulatory pipeline, "will drive procedure volume
and product
revenues in this fast growing sector of the aesthetic market," observed
Moretti.
All of these new products and procedures are covered extensively in the
new Aesthetic Technologies and Business Opportunities market study, authored
by Moretti. This comprehensive study, released by Medical Insight in May
2003, provides a detailed analysis and market forecast related to emerging
aesthetic technologies and procedures.
To receive an Executive Summary of this new market study, or a subscription
to THE Aesthetic Guide, contact Katie Davis at Kdavis@MiiNews.com,
call 949/830-5409 or visit www.MiiNews.com.
Public companies participating in the aesthetic market include: Allergan
(NYSE:AGN), Candela Corporation (Nasdaq:CLZR), DUSA (Nasdaq:DUSA), Inamed
(Nasdaq:IMDC), Lumenis (Nasdaq:LUME), and Palomar (Nasdaq:PMTI).
Contact:
Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
AESTHETIC
BUYERS GUIDE PREVIEWS AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING
MISSION VIEJO, Calif.--(BUSINESS WIRE)--March 11, 2003--The March issue
of THE Aesthetic Guide magazine provides an advance preview of
the newest technologies and skincare products scheduled for release at
the upcoming AAD annual meeting in San Francisco.
Smoothbeam diode laser treatment of acne and acne scars is featured as
the cover news article. This technology, developed by Candela Corporation
(Nasdaq:CLZR), promises physicians and their acne patients an alternative
to pharmaceutical treatments.
Lumenis (Nasdaq:LUME) will also introduce a series of new aesthetic devices
at the AAD show, including the ClearLight for acne treatment and ReLume
for scars and stretchmarks.
Dozens of other new technologies are featured in the March issue of the
THE Aesthetic Guide. "This is one of the largest and most exciting
issues we have ever published," commented Michael Moretti, Editor of the
THE Aesthetic Guide, and President of Medical Insight, Inc.
"The aesthetic market is truly undergoing a renaissance of innovation
and growth, producing an impressive pipeline of breakthrough products
and treatments," said Moretti. "Due to mailing THE Aesthetic Guide
earlier this month, our 16,000 readers will learn about these new products
before they even debut at the AAD show."
Many of these emerging aesthetic technologies will also be discussed
at the Aesthetic Technologies Business Forum, sponsored by Medical Insight,
Inc. on March 24th in San Francisco. In addition, Mr. Moretti will present
an Executive Briefing related to the forthcoming New Aesthetic Technologies
and Business Opportunities market study. This comprehensive study, which
is scheduled for publication by Medical Insight in April 2003, will provide
a detailed analysis and market forecast related to emerging aesthetic
technologies.
The Aesthetic Technologies Business Forum is a private business meeting
with no financial connection to manufacturers or medical societies. Advance
registration is required to attend.
To register, contact Katie Davis at Kdavis@MiiNews.com,
or call (949) 830-5409. For information on products and services offered
by Medical Insight, Inc., visit www.MiiNews.com.
Public companies participating in the aesthetic market include: Allergan
(NYSE: AGN), Candela Corporation (Nasdaq:CLZR), Inamed (Nasdaq:IMDC),
Lumenis (Nasdaq:LUME), Palomar (Nasdaq:PMTI), and PhotoMedex (Nasdaq:PHMD).
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
BUSINESS
DEVELOPMENT FORUM FOCUSES ON NEWEST AESTHETIC TECHNOLOGIES AND MARKET
RESEARCH
MISSION VIEJO, Calif.--(BUSINESS WIRE)--Feb. 27, 2003--On March 24th
in San Francisco the "THE Aesthetic Guide" and Medical Insight
will present the newest innovations in aesthetic technologies, products
and procedures via a highly condensed business forum. The "Aesthetic
Technologies Business Forum" offers industry executives an advance
opportunity to evaluate numerous new technologies that will make a major
impact on the cosmetic treatment market in the near future. This business
development forum will include the exclusive release of results from a
recent aesthetic practice survey conducted by Medical Insight, including
current procedure trends, pricing statistics, and other market research
data.
In addition, Michael Moretti, President of Medical Insight, Inc. and
Editor of the "THE Aesthetic Guide," will present an Executive Briefing
related to the forthcoming New Aesthetic Technologies and Business Opportunities
market study. This comprehensive study, which is scheduled for publication
by Medical Insight in April 2003, will provide a detailed analysis and
market forecast related to emerging aesthetic technologies.
Some of the new technologies and products scheduled for review at the
"Aesthetic Technologies Business Forum" include: R-F based systems for
multiple applications; Ultrasound and electrical stimulation for face
lifts; LEDs for wrinkle reduction; Laser and ultrasound-based cellulite
reduction systems; Bioengineered anti-aging topicals; and light-activated
drugs for photorejuvenation. Attendees at the "Aesthetic Technologies
Business Forum" will have the unique opportunity to preview the future
of aesthetic practice. This interactive meeting also includes networking
with the inventors who created these new products and procedures. As a
result, Forum participants will leave this event with inside information
that provides a major strategic advantage. They will have the knowledge
to screen and select only the devices and products which will be successful
in the near future.
The "Aesthetic Technologies Business Forum" is a private business meeting
with no financial connection to manufacturers or medical societies. Advance
registration is required to attend.
To register, contact Katie Davis at Kdavis@MiiNews.com,
or call (949) 830-5409. For information on products and services offered
by Medical Insight, Inc., visit www.MiiNews.com.
Public companies participating in the aesthetic market include: Allergan
(NYSE:AGN), Candela Corporation (Nasdaq:CLZR), Inamed (Nasdaq:IMDC), Lumenis
(Nasdaq:LUME), Palomar (Nasdaq:PMTI), and PhotoMedex (Nasdaq:PHMD).
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
LED TECHNOLOGY PROMISES NEXT GENERATION OF AESTHETIC
TREATMENTS
MISSION VIEJO, CALIF. - December 3, 2002 - Forbes magazine has published
the first news report on a novel light-based technology that is poised
to evolve into sophisticated aesthetic treatment devices for the physician
and home consumer markets. A feature article in the December 9th issue
of Forbes includes an exclusive interview with David H. McDaniel, M.D.,
inventor of the GentleWaves LED-based treatment and founder of Light BioScience,
LLC (Virginia Beach, Va.).
GentleWave™ is a new light-based, non-thermal photorejuvenation
procedure designed to improve the appearance of photoaged or environmentally
damaged skin in all ethnic skin types. This proprietary patent-pending
Photomodulation process utilizes non-laser, light-emitting diodes (LEDs)
operating at specially calibrated parameters which are thought to photoactivate
or photoinhibit the normal cellular activity of living cells.
Light BioScience is completing long-term follow-up on a multicenter clinical
study of 90 photoaged patients. Each patient received a total of eight
treatments. "We've also performed skin biopsies that show actual collagen
production in the papillary dermis within weeks of beginning treatment,"
noted Robert Weiss, M.D., an assistant professor of dermatology at Johns
Hopkins University School of Medicine and clinical investigator for the
company.
Light BioScience expects LED Photomodulation to be commercially available
by early 2003 at prices significantly lower than technologies and treatments
currently on the market. Data from the on-going photo-aging studies will
also be submitted to the FDA.
Michael Moretti of Medical Insight is an aesthetic industry analyst and
author of the Global Aesthetic Market. He predicts that "LED technology
will evolve rapidly as an alternative medical light source which is far
less expensive to manufacture than lasers. With the low cost of manufacturing,
and ability to mass produce LED devices, these products could be sold
directly to consumers for home treatments within a relatively short period
of time."
The Global Aesthetic Market Study provides the only single source
report for worldwide data on the fastest growing segments of the lucrative
aesthetic market, including: Botox, dermal fillers, skin rejuvenation
technologies, light-based hair removal, anti-aging products, and a number
of other popular procedures.
To order the Global Aesthetic Market Study or review the Executive
Summary, contact Katie Davis at KDavis@MiiNews.com,
or call (949) 830-5409. For information on other products and services
offered by Medical Insight, Inc., visit www.MiiNews.com.
Contact: David H. McDaniel, M.D.
LightBioscience, LLC
(757) 425-6900
www.lightbioscience.com
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
MEDICAL INSIGHT REPORTS BOTOX® TREND FUELS DRAMATIC
GROWTH IN AESTHETIC MARKET
MISSION VIEJO, CALIF. - August 26, 2002 - Data from the most recent market
report published by Medical Insight, Inc., indicates that Botox® is among
the world's most popular cosmetic procedures with volumes up more than
40% since 2000.
According to Medical Insight's comprehensive study on the Global Aesthetic
Market, by 2007 more than 8 million procedures will be performed annually
using Botox and similar products that are currently in the regulatory
pipeline. In 2001, prior to FDA approval, Botox cosmetic manufacturer
Allergan (Irvine, Calif.) sold an estimated $300 million worth of the
product. This company is predicting that total sales will increase by
approximately 40% in 2002 in part fueled by the launch of an extensive
consumer advertising campaign.
Michael Moretti, aesthetic industry analyst and author of the Global
Aesthetic Market, commented that "according to our most recent aesthetic
user survey results, Botox and dermal fillers are presently the most profitable
procedures for practices to offer." He predicts that the "use of Botox
will continue to grow at a compound annual rate of 15%. And as Allergan's
consumer marketing campaign drives millions of new patients to aesthetic
practices where they will purchase Botox, we will see an acceleration
in the volume of complementary treatments - as well as increased sales
of anti-aging skincare products."
Most aesthetic practices offer Botox in conjunction with other skin rejuvenation
treatments and products. Many combine Botox and light-based IPL photorejuvenation
(manufactured by Lumenis, Santa Clara, Calif.) to address the full face
in a procedure commonly referred to as a "photofacial." This is "one of
the most profitable treatments offered by aesthetic practices," said Moretti.
"Volumes are expected to increase from 1.5 million in 2001 to over 2 million
photofacial procedures this year. Lumenis has taken a leadership role
in co-marketing Botox and IPL photorejuvenation as a complementary treatment
package."
The Global Aesthetic Market Study provides the only single source report
for worldwide data on the fastest growing segments of the lucrative aesthetic
market, including: Botox, dermal fillers, skin rejuvenation technologies,
light-based hair removal, anti-aging products, and a number of other popular
procedures.
To order the Global Aesthetic Market Study or review the Executive Summary,
contact Katie Davis at KDavis@MiiNews.com, or call (949) 830-5409. For
information on other products and services offered by Medical Insight,
Inc., visit www.MiiNews.com.
Public companies participating in the aesthetic market include: Advanced
Tissue Sciences, Allergan (NYSE: AGN), ArthroCare, Candela, ICN (NYSE:
ICN), Inamed, Laserscope, Lumenis (Nasdaq:LUME), Palomar, and PhotoMedex.
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
MEDICAL INSIGHT PRESENTS GLOBAL AESTHETIC MARKET DATA
AT WORLD CONGRESS
MISSION VIEJO, CALIF. - June 20, 2002 - Data from a new Global Aesthetic
Market Study will be released at an Executive Briefing in Paris during
the World Congress of Dermatology (July 1 - 5, 2002).
According to this latest market study from Medical Insight, there were
more than nine million aesthetic procedures performed in 2001, representing
a 50% increase over the previous year. The highest volume non-surgical
aesthetic procedures at this time include: botulinum toxin injections
(Botox), chemical peels, collagen injections, microdermabrasion, laser-based
epilation, and IPL photorejuvenation.
"I have been tracking the aesthetic market for over ten years,"
commented study author and industry analyst Michael Moretti, "and
procedure volumes continue to increase significantly each year. The recent
FDA approval of Botox for cosmetic use will accelerate aesthetic market
development across the board as Allergan's consumer marketing campaign
drives millions of new patients to aesthetic practices where they will
purchase Botox and complimentary treatments as well as anti-aging skincare
products."
The Global Aesthetic Market Study provides the only single source report
for worldwide data on the fastest growing segments of the lucrative aesthetic
market. This study includes: leading competitor profiles, technology assessments,
clinical results, five-year product sales projections, procedure statistics
and five-year revenue forecasts, as well as a competitive market share
analysis.
Specific market segments covered include: Light-Based Devices and Treatments;
Botox and Competitive Products in the Pipeline; Dermal Fillers & Injectables;
Microdermabrasion and Skin Rejuvenation Technologies; and Anti-Aging Topicals.
To attend the Executive Briefing in Paris, contact Michael Moretti at:
Mmoretti@MiiNews.com
To order the Global Aesthetic Market Study or review the Executive Summary,
contact Katie Davis at Kdavis@MiiNews.com
or call (949) 830-5409. For information on other products and services
offered by Medical Insight, Inc., visit www.MiiNews.com
Public companies participating in the aesthetic market include: Advanced
Tissue Sciences (Nasdaq: ATIS), Allergan (NYSE: AGN), ArthroCare (Nasdaq:ARTC),
(Candela Corporation (Nasdaq:CLZR), ICN (NYSE: ICN), Innamed (Nasdaq:IMDC),
Laserscope (Nasdaq:LSCP), Lumenis (Nasdaq:LUME), Palomar (Nasdaq:PMTI),
and PhotoMedex (Nasdaq:PHMD).
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: Mmoretti@MiiNews.com
LIGHT-BASED DERMATOLOGY TREATMENTS CHALLENGE PHARMACEUTICALS
MISSION VIEJO, CALIF. - April 22, 2002 - according to the latest market
study from Medical Insight, a new generation of laser and light-based
technologies will offer treatment alternatives for major diseases, including:
acne, psoriasis and actinic keratoses. According to The Market for Advanced
Light-Based Dermatology Treatments study, these new devices offer significant
benefits over existing therapies. As a result, they are likely to gain
rapid acceptance as both an alternative and an adjunct to current treatments.
This is especially true for the large acne market.
Three light-based devices are currently being sold for the treatment
of acne. By 2006, more than 15,000 physicians worldwide are likely to
use similar systems. This will account for over $1.3 billion in annual
treatment fees, some of which will cannibalize the $4.2 billion spent
on acne medications.
Six light-based systems are now available to treat psoriasis. More than
4,000 physicians worldwide are expected to use these devices by 2006.
Currently, about $695 million per year is spent on psoriasis medications.
Two companies have launched photodynamic therapy (PDT) treatments for
actinic keratoses (AKs). Meanwhile, other developers are nearing launch
of similar therapies. Annual volume of AK treatments with light-based
therapies is forecast at over 3 million procedures in 2006.
"Diagnosis and treatment of skin diseases, including skin cancer,
is one of the most promising areas of business development at this time,"
commented study author Michael Moretti. "Leading edge companies are
forging the pathway for new business opportunities based on adding light-devices
to dermatology practices. These new approaches involve the conjunctive
use of light-activated drugs. Existing pharmaceuticals will also be used
in combination therapies that produce improved clinical outcomes."
Public companies commercializing Advanced Light-Based Dermatology Treatments
include: Candela Corporation (Nasdaq:CLZR), DUSA Pharmaceuticals, (Nasdaq
NMS:DUSA), Lumenis (Nasdaq:LUME), Miravant Medical Technologies (Nasdaq:MRVT),
and PhotoMedex (Nasdaq:PHMD).
To obtain a copy of Medical Insight's new Market for Advanced Light-Based
Dermatology Treatments Study, contact: Katie Davis at KDavis@MiiNews.com,
or call (949) 830-5409. For information on other studies offered by Medical
Insight, Inc., visit www.MiiNews.com.
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
MEDICAL INSIGHT NEW DERMATOLOGY STUDY DEFINES $10 BILLION GROWTH MARKETS
MISSION VIEJO, CALIF., - February 13, 2002 - Medical Insight, Inc., a
leading source of medical market data, will soon release the latest and
most comprehensive study on the Market for Advanced Light-Based Dermatology
Treatments.
This confidential report focuses on a core group of the most common skin
disorders including: acne, psoriasis and actinic keratosis. According
to the author, Michael Moretti, these three disorders alone combine to
form an estimated $10 billion annual market on a global basis.
Mr. Moretti will present an executive briefing on the results of this
study during the upcoming American Academy of Dermatology annual meeting
in New Orleans (Feb. 22 - Feb. 25). Contact Mr. Moretti directly at: MMoretti@MiiNews.com
to attend this briefing.
The Market for Advanced Light-Based Dermatology Treatments study provides
an in-depth analysis by application that includes procedure volumes and
revenues, device and drug sales, market share by supplier, and market
performance projected over a five-year period. Technology assessments
cover both existing and emerging light-based technologies.
This study also features an analysis of clinical results by application,
in comparison to standard drug treatments.
"Innovative light-based technologies have physicians re-thinking
their treatment regimens," according to Moretti. "Ever mindful
of the adverse side effects associated with many of the drug therapies
available to treat these disorders, physicians and patients alike are
excited to have high-tech, alternative treatment options."
"Early clinical trials of light-based treatments point to fewer
side effects, and less patient discomfort. However, even more exciting
to physicians is the opportunity to participate in this enormous revenue
stream."
New light-based systems are entering the market rapidly, and pharmaceutical
companies are evaluating the combined use of drugs and light to tap into
this lucrative new market segment. The Market for Advanced Light-Based
Dermatology Treatments study looks at the efficacy and market impact of
new devices targeted to each application.
Devices currently vying for a piece of the $5 billion acne treatment
market include: Radiancy's ClearTouch System and ClearLight by Lumenis.
In addition, several other manufacturers have multi-application systems
that can potentially be used for acne.
Light-based technologies targeted at the psoriasis segment of the dermatology
market include: Candela's C-Beam dye laser, Cynosure's Photogenica system,
the Lumenis BClear UVB Phototherapy System, and the XTRAC excimer laser
from PhotoMedex. Miravant Medical Technologies announced in January that
it has begun clinical trials of photodynamic therapy (PDT) for psoriasis
as well.
PDT treatments for actinic keratosis discussed in this study include
the Levulan Kerastick from DUSA (marketed by Berlex) and the new Metvix
technology co-developed by Galderma and PhotoCure.
Public companies commercializing Advanced Light-Based Dermatology Treatments
include: Candela Corporation (Nasdaq:CLZR), DUSA Pharmaceuticals, (Nasdaq
NMS:DUSA), Lumenis (Nasdaq:LUME), Mirivant Medical Technologies (Nasdaq:MRVT),
and PhotoMedex (Nasdaq:PHMD).
To obtain a copy of Medical Insight's new Market for Advanced Light-Based
Dermatology Treatments Study, contact: Katie Davis at KDavis@MiiNews.com,
or call (949) 830-5409. For information on other studies offered by Medical
Insight, Inc., visit www.MiiNews.com.
Contact: Michael Moretti, Editor
Medical Insight, Inc.
(949) 830-5409
Email: MMoretti@MiiNews.com
HOME EPILATION MARKET TO REACH $9.5 BILLION IN 2003
MISSION VIEJO, Calif.--(BW HealthWire)--Jan. 2, 2002--Medical Insight,
Inc., the leading source of business information on aesthetic technologies
and markets, has released its newest market study covering the Worldwide
Epilation Market. Hair removal methods and market segments analyzed in
this study include laser and light-based hair removal, electrolysis, and
waxing for both the professional and home markets.
Since the introduction of light-based hair removal, the worldwide epilation
market has undergone dramatic changes. The number of devices installed
in medical, aesthetic, electrology, spa and salon locations is predicted
to exceed 17,000 units in the 5-year forecast period, according to study
author Michael Moretti. Last year, more than 5 million light-based hair
removal treatments were performed, generating $1.3 billion in fees for
service providers. Light-based treatment is topped only by waxing, which
will bring in more than $3.3 billion through more than 111 million treatments.
In contrast, electrolysis will generate only about $436 million this year
in treatment revenues.
Procedure growth is being fueled by lower treatment prices, heightened
advertising, and consumer awareness of the procedure. As this happens,
more and more practitioners who offered other hair removal treatments
- like electrolysis and waxing - are incorporating light-based hair removal
into their businesses. Approximately 5% of the 6,500 spas in the U.S.
have said they plan to add laser hair removal to their menu of services
over the coming year. The greatest potential for hair removal devices
lies in the home consumer market, according to Mr. Moretti. Home-based
epilation product sales reached $8.7 billion in 1991, and is expected
to grow to more than $9.5 billion by 2003. Analysts believe that lasers
will be the next innovation in the home market, and major consumer products
manufacturers currently have R&D projects underway to develop low-cost
light-based epilation devices. "I believe that a laser-razor consumer
product will have a major impact on the market within the next few years,"
observed Mr. Moretti.
Public companies participating in the Worldwide Epilation Market include:
Candela Corporation (Nasdaq:CLZR); Laserscope (Nasdaq:LSCP), Lumenis (Nasdaq:LUME),
and Palomar (Nasdaq:PMTI).
To obtain a copy of Medical Insight's Worldwide Epilation Market Study,
contact: Katie Davis, at KDavis@MiiNews.com, or call (949) 830-5409. For
information on other studies produced by Medical Insight, visit www.MiiNews.com.
Contact: Medical Insight, Inc.
Michael Moretti, 949/830-5409
Email: mmoretti@MiiNews.com
THE Aesthetic Show Advances $34 Billion Market
LAS VEGAS, May 14 /PRNewswire/ -- More than 2,000 physicians, researchers, Wall Street analysts and industry executives will gather at the Mandalay Bay Resort for THE Aesthetic Show, May 30 - June 1, 2008. With the most comprehensive and progressive medical aesthetic educational program ever assembled in the U.S., this unique venue is focused on accelerating and sustaining the development of a $34 billion global market for aesthetic treatments.
"THE Aesthetic Show offers a weekend immersion in everything new and relevant in the aesthetic procedure business," said Michael Moretti, President of Medical Insight, Inc. and Chairman of THE Aesthetic Show. "We specifically designed this sophisticated show to serve the needs of both aesthetic practices and the supporting industry by breaking down the artificial barriers between various competing medical subspecialties. Unlike exclusive medical society meetings, THE Aesthetic Show makes high-level educational content and new ideas accessible to all of our attendees."
Faculty members of THE Aesthetic Show include the top anti-aging, cosmetic surgery and aesthetic medicine experts in the world, as well as some of the highest visibility celebrity physicians in the field. "Our attendees will enjoy three days of direct access to over 50 of the elite thought leaders who are driving the advancement and cultural mainstreaming of aesthetic medicine," explained Mr. Moretti. "Every relevant subject from the latest plastic surgery techniques to avant-garde body shaping and home use devices will be presented and evaluated in one weekend. This scientific program also offers 25 intensive one-hour workshops featuring interactive training sessions with patient treatments."
Leading corporate sponsors of THE Aesthetic Show include: Allergan Medical (NYSE: AGN), BioForm Medical (Nasdaq: BFRM), Candela (Nasdaq: CLZR), Cutera (Nasdaq: CUTR), Cynosure (Nasdaq: CYNO), Dermik Aesthetics, Galderma Laboratories, Johnson & Johnson (NYSE: JNJ), Mentor Corporation (NYSE: MNT), Merz Pharmaceuticals, Palomar Medical Technologies (Nasdaq: PMTI), Syneron (Nasdaq: ELOS) and Thermage (Nasdaq: THRM).
According to a recent research report released by Medical Insight (miinews.com), the global market for aesthetic products will exceed $5.4 billion in 2008. This dynamic market is expected to reach $8.5 billion by 2012. On a procedure level, aesthetic practices will perform 89 million treatments in 2008 generating $34 billion in practice revenues. Annual procedure volume will grow to 139 million treatments by 2012, producing $52 billion in patient fees, as consumers increasingly opt for more advanced, premium-priced procedures.
THE Aesthetic Show will be held at the Mandalay Bay Resort in Las Vegas from May 30 - June 1, 2008. To register or view the program, visit http://www.aestheticshow.com or contact Silvia Kraniess at Silvia@aestheticshow.com.
About Medical Insight, Inc.
Medical Insight, Inc. is the industry leader in sector and custom market research. Led by founder Michael Moretti, Medical Insight, Inc. has reported data for over 20 years on procedure volume, revenues, product sales, new product introductions, market forecasts and trend analysis. For information on products and services offered by Medical Insight, Inc., visit http://www.MiiNews.com.
Contact: Medical Insight, Inc.
Michael Moretti, 949/830-5409
Email: mmoretti@MiiNews.com
|
|
